1,050
Participants
Start Date
October 9, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
January 31, 2024
SARS-CoV-2 Protein Subunit Recombinant Vaccine
SARS-CoV-2 RBD subunit recombinant protein, manufactured by PT. Bio Farma
Active Comparator
Covovax
Bali Mandara Hospital, Denpasar
Universitas Udayana Hospital, Denpasar
RSUD Hj. Anna Lasmanah, Banjarnegara
Abdoel Moeloek Hospital, Bandar Lampung
Rumpin Primary Health Care, Bogor
Duren Seribu Primary Health Care, Depok
Pasir Putih Primary Health Care, Depok
Universitas Mataram Hospital, Mataram
M Djamil Hospital, Padang
RS Universitas Andalas, Padang
Lead Sponsor
Center for Child Health Universitas Gadjah Mada (CCH-PRO UGM
UNKNOWN
Cipto Mangunkusumo Hospital/Department of Child Health, Faculty of Medicine, University of Indonesia, Jakarta
UNKNOWN
Faculty of Medicine, Andalas University
UNKNOWN
PT Bio Farma
INDUSTRY